Latest filing published 13 Apr 2017 for Hikma Pharmaceuticals PLC, €54k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -37.8%Entry £19.19 · Close at T+365 £11.93
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Michael Raya: trading record in brief
Michael Raya discloses dealings in Hikma Pharmaceuticals PLC to RNS (LSE). Over a trading history stretching from 11 November 2013 to 12 April 2017, the count stands at 4 filings.
On the open market, the record shows 1 purchase worth €185k and 3 sales worth €787k. The net balance comes to €602k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2017, the count stands at 1 purchase and 1 sale.
The newest entry dates from 13 April 2017: an open-market sale of €54k, in Hikma Pharmaceuticals PLC. The most recent open-market purchase was published on 11 April 2017, 3,499 days ago. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for notifying a trade is three business days (UK MAR). Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Companies and markets linked to Michael Raya
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,753 shares6.8% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083FCA-NSM:LSE20170413085833_13193764_20200330131459524_9816
- 19,655 shares23.3% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083FCA-NSM:LSE20170411160156_13191317_20200330131459224_8000-2Canonical exit: 9 Jul 2017 (T+90)
- 19,047 shares@ £22.42100.0% of flowFCA-NSM:LSE20160519101717_012822228_20200330143609873_14158-1
- 12,200 shares@ £12.06FCA-NSM:LSE20131111165507_011770589_20200330164714185
4 of 4 declarations